Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)

Lehigh Valley Health Network, Allentown

University Of Pennsylvania, Philadelphia

University Of Virginia Health System, Charlottesville

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Vanderbilt-Ingram Cancer Center, Nashville

Indiana University Health Melvin And Bren Simon Cancer Center, Indianapolis

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

Vanderbilt-Ingram Cancer Center, Nashville